Anhui Wanbang Pharmaceutical Technology Co.,Ltd. (SHE:301520)

SHE:301520 Revenue

Anhui Wanbang Pharmaceutical Technology had revenue of 30.54M CNY in the quarter ending March 31, 2026, a decrease of -57.02%. This brings the company's revenue in the last twelve months to 233.67M, down -35.09% year-over-year. In the year 2025, Anhui Wanbang Pharmaceutical Technology had annual revenue of 274.18M, down -27.67%.

• Revenue (ttm): 233.67M
• Revenue Growth: -35.09%
• P/S Ratio: 10.50
• Revenue / Employee: 631.54K
• Employees: 362
• Market Cap: 2.45B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	274.18M	-104.91M	-27.67%
Dec 31, 2024	379.09M	37.28M	10.91%
Dec 31, 2023	341.81M	81.03M	31.07%
Jan 1, 2023	260.78M	49.69M	23.54%
Dec 31, 2021	211.09M	71.96M	51.72%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error